Listing 1 - 7 of 7 |
Sort by
|
Choose an application
Using in-depth qualitative interviews, authors Herbert J. Rubin and Irene S. Rubin have researched topics ranging from community redevelopment programs to the politics of budgeting and been energized by the depth, thoroughness, and credibility of what was revealed. They describe in-depth qualitative interviewing from beginning to end, from its underlying philosophy and assumptions to project design, analysis and write-up.
Qualitative methods in social research --- Interviewing --- Interviewing in sociology --- Sociology --- Interviews as Topic --- Entretiens --- Entretiens en sociologie --- methods --- Interviewing. --- Interviewing in sociology. --- Interviews as Topic. --- methods. --- Entretiens. --- Entretiens en sociologie. --- #SBIB:303H32 --- 001.891 --- Qualitative Research --- 001.891 Wetenschappelijk onderzoek. Research. Onderzoekmethoden --- Wetenschappelijk onderzoek. Research. Onderzoekmethoden --- Waarneming en participerende waarneming, gecontroleerde observatie, groepsdiscussie (vragenlijsten, interviews, experimenten) --- Research, Qualitative --- Anthropology, Cultural --- Focus Groups --- Group Interviews --- Interviewers --- Interviews, Telephone --- Oral History as Topic --- Group Interview --- Interview, Group --- Interview, Telephone --- Interviewer --- Interviews, Group --- Telephone Interview --- Telephone Interviews --- Questioning --- Counseling --- Focus groups --- Interviews --- Social case work --- Methodology
Choose an application
Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.
Medicine --- papillary thyroid cancer --- SUV PET/CT --- BRAF V600E --- immune checkpoint inhibitors (ICIs) --- ipilimumab --- nivolumab --- prolactinoma --- Cushing’s disease --- aggressive pituitary tumor --- aggressive PitNET --- aggressive pituitary adenoma --- pituitary carcinoma --- adrenocortical cancer --- adrenal adenomas --- adrenal tumors --- p53 --- p27 --- ki-67 --- reticulin --- mitotane --- adjuvant treatment --- recurrence --- recurrence free survival --- timing --- intratumoral heterogeneity --- thyroid tumor --- BRAF --- RET/PTC rearrangements --- RAS mutation --- adrenal cortex --- carcinoma --- angiogenesis --- gene expression --- osteopontin --- hyaluronan synthase 1 --- multikinase inhibitors --- sorafenib --- lenvatinib --- differentiated thyroid cancer --- radioiodine resistance --- predictive marker --- predictors --- response to treatment --- survival --- information needs and preferences --- focus group interview --- personalized medicine --- neuroendocrine tumours --- phaeochromocytoma --- paraganglioma --- molecular clusters --- n/a --- Cushing's disease
Choose an application
Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.
Medicine --- papillary thyroid cancer --- SUV PET/CT --- BRAF V600E --- immune checkpoint inhibitors (ICIs) --- ipilimumab --- nivolumab --- prolactinoma --- Cushing’s disease --- aggressive pituitary tumor --- aggressive PitNET --- aggressive pituitary adenoma --- pituitary carcinoma --- adrenocortical cancer --- adrenal adenomas --- adrenal tumors --- p53 --- p27 --- ki-67 --- reticulin --- mitotane --- adjuvant treatment --- recurrence --- recurrence free survival --- timing --- intratumoral heterogeneity --- thyroid tumor --- BRAF --- RET/PTC rearrangements --- RAS mutation --- adrenal cortex --- carcinoma --- angiogenesis --- gene expression --- osteopontin --- hyaluronan synthase 1 --- multikinase inhibitors --- sorafenib --- lenvatinib --- differentiated thyroid cancer --- radioiodine resistance --- predictive marker --- predictors --- response to treatment --- survival --- information needs and preferences --- focus group interview --- personalized medicine --- neuroendocrine tumours --- phaeochromocytoma --- paraganglioma --- molecular clusters --- n/a --- Cushing's disease
Choose an application
Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.
papillary thyroid cancer --- SUV PET/CT --- BRAF V600E --- immune checkpoint inhibitors (ICIs) --- ipilimumab --- nivolumab --- prolactinoma --- Cushing’s disease --- aggressive pituitary tumor --- aggressive PitNET --- aggressive pituitary adenoma --- pituitary carcinoma --- adrenocortical cancer --- adrenal adenomas --- adrenal tumors --- p53 --- p27 --- ki-67 --- reticulin --- mitotane --- adjuvant treatment --- recurrence --- recurrence free survival --- timing --- intratumoral heterogeneity --- thyroid tumor --- BRAF --- RET/PTC rearrangements --- RAS mutation --- adrenal cortex --- carcinoma --- angiogenesis --- gene expression --- osteopontin --- hyaluronan synthase 1 --- multikinase inhibitors --- sorafenib --- lenvatinib --- differentiated thyroid cancer --- radioiodine resistance --- predictive marker --- predictors --- response to treatment --- survival --- information needs and preferences --- focus group interview --- personalized medicine --- neuroendocrine tumours --- phaeochromocytoma --- paraganglioma --- molecular clusters --- n/a --- Cushing's disease
Choose an application
Family Practice. --- Interviews as Topic. --- Physician-Patient Relations. --- Disease --- Group Interviews --- Interviewers --- Interviews, Telephone --- Oral History as Topic --- Group Interview --- Interview, Group --- Interview, Telephone --- Interviewer --- Interviews, Group --- Telephone Interview --- Telephone Interviews --- Family Practices --- Practice, Family --- Practices, Family --- psychology. --- Theses --- Family practice --- Interviews --- DISEASE --- psychology --- Family practice. --- Interviews. --- Physician-patient relations. --- Psychology. --- Doctor Patient Relations --- Physician Patient Relations --- Physician Patient Relationship --- Doctor-Patient Relations --- Doctor Patient Relation --- Doctor-Patient Relation --- Physician Patient Relation --- Physician Patient Relationships --- Physician-Patient Relation --- Relation, Doctor Patient --- Relation, Doctor-Patient --- Relation, Physician Patient --- Relation, Physician-Patient --- Relations, Doctor Patient --- Relations, Doctor-Patient --- Relations, Physician Patient --- Relations, Physician-Patient --- Relationship, Physician Patient --- Relationships, Physician Patient --- Family Practice --- Interviews as Topic --- Physician-Patient Relations
Choose an application
Family Practice. --- Communication. --- Interviews as Topic. --- Physician-Patient Relations. --- Disease --- Group Interviews --- Interviewers --- Interviews, Telephone --- Oral History as Topic --- Group Interview --- Interview, Group --- Interview, Telephone --- Interviewer --- Interviews, Group --- Telephone Interview --- Telephone Interviews --- Communication Programs --- Communications Personnel --- Misinformation --- Personal Communication --- Communication Program --- Communication, Personal --- Personnel, Communications --- Program, Communication --- Programs, Communication --- Family Practices --- Practice, Family --- Practices, Family --- psychology. --- Theses --- 44.62 general practice. --- General practitioners. --- Medical consultation. --- Physician and patient. --- Physician-patient relation. --- Doctor Patient Relations --- Physician Patient Relations --- Physician Patient Relationship --- Doctor-Patient Relations --- Doctor Patient Relation --- Doctor-Patient Relation --- Physician Patient Relation --- Physician Patient Relationships --- Physician-Patient Relation --- Relation, Doctor Patient --- Relation, Doctor-Patient --- Relation, Physician Patient --- Relation, Physician-Patient --- Relations, Doctor Patient --- Relations, Doctor-Patient --- Relations, Physician Patient --- Relations, Physician-Patient --- Relationship, Physician Patient --- Relationships, Physician Patient --- Social Communication --- Communication, Social --- Communications, Social --- Social Communications --- Family Practice --- Communication --- Interviews as Topic --- Physician-Patient Relations --- psychology
Choose an application
The ability to obtain health care is fundamental to the security, stability, and well-being of poor families. Government-sponsored programs provide temporary support, but as families leave welfare for work, they find themselves without access to coverage or care. The low-wage jobs that individuals in transition are typically able to secure provide few benefits yet often disqualify employees from receiving federal aid. Drawing upon statistical data and in-depth interviews with over five hundred families in Oregon, Karen Seccombe and Kim Hoffman assess the ways in which welfare reform affects the well-being of adults and children who leave the program for work. We hear of asthmatic children whose uninsured but working mothers cannot obtain the preventive medicines to keep them well, and stories of pregnant women receiving little or no prenatal care who end up in emergency rooms with life-threatening conditions. Representative of poor communities nationwide, the vivid stories recounted here illuminate the critical relationship between health insurance coverage and the ability to transition from welfare to work.
Health care reform. --- Health care reform --- Health insurance --- Health services accessibility --- Health Care Reform --- Interviews as Topic --- Insurance, Health --- Socioeconomic Factors --- Health Services Accessibility --- Oregon --- Social Welfare --- Delivery of Health Care --- Northwestern United States --- Health Planning --- Health Policy --- Data Collection --- Population Characteristics --- Sociology --- Insurance --- Patient Care Management --- Epidemiologic Methods --- Social Sciences --- Health Care Evaluation Mechanisms --- Financing, Organized --- Information Science --- Public Policy --- Health Care Quality, Access, and Evaluation --- Health Care Economics and Organizations --- United States --- Health Care --- Health Services Administration --- Quality of Health Care --- Anthropology, Education, Sociology and Social Phenomena --- Public Health --- North America --- Investigative Techniques --- Social Control Policies --- Economics --- Social Control, Formal --- Americas --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Policy --- Environment and Public Health --- Geographic Locations --- Geographicals --- Access to health care --- Accessibility of health services --- Availability of health services --- Medical care --- Health plans, Prepaid --- Medical care, Prepaid --- Medical insurance --- Prepaid health plans --- Prepaid medical care --- Sickness insurance --- Health reform --- Health system reform --- Healthcare reform --- Medical care reform --- Reform of health care delivery --- Reform of medical care delivery --- Access --- Ambulance service --- Home care services --- Hospitals --- Medically uninsured persons --- Surgical clinics --- Medical policy --- Prospective payment --- Emergency services --- Outpatient services --- Rehabilitation services --- Accessibility, Health Services --- Contraceptive Availability --- Health Services Geographic Accessibility --- Program Accessibility --- Access to Health Care --- Accessibility of Health Services --- Availability of Health Services --- Accessibility, Program --- Availability, Contraceptive --- Health Services Availability --- Medically Underserved Area --- Healthcare Reform --- Health Care Reforms --- Healthcare Reforms --- Reform, Health Care --- Reform, Healthcare --- Reforms, Health Care --- Reforms, Healthcare --- Group Health Insurance --- Health Insurance --- Health Insurance, Voluntary --- Health Insurance, Group --- Insurance, Group Health --- Insurance, Voluntary Health --- Voluntary Health Insurance --- Group Interviews --- Interviewers --- Interviews, Telephone --- Oral History as Topic --- Group Interview --- Interview, Group --- Interview, Telephone --- Interviewer --- Interviews, Group --- Telephone Interview --- Telephone Interviews --- Community Services --- Services, Community --- Community Service --- Service, Community --- Welfare, Social --- Public Assistance --- Factors, Socioeconomic --- High-Income Population --- Inequalities --- Land Tenure --- Standard of Living --- Factor, Socioeconomic --- High Income Population --- High-Income Populations --- Inequality --- Living Standard --- Living Standards --- Population, High-Income --- Populations, High-Income --- Socioeconomic Factor --- Tenure, Land --- Access To Medicines --- Access to Contraception --- Access to Health Services --- Access to Medications --- Access to Therapy --- Access to Treatment --- Contraception Access --- Contraceptive Access --- Medication Access --- Access To Medicine --- Access to Contraceptions --- Access to Medication --- Access to Therapies --- Access to Treatments --- Access, Contraception --- Access, Contraceptive --- Access, Medication --- Contraception, Access to --- Contraceptive Accesses --- Medication Accesses --- Medication, Access to --- Therapy, Access to --- Treatment, Access to --- Social Inequalities --- Social Inequality --- Inequalities, Social --- Inequality, Social
Listing 1 - 7 of 7 |
Sort by
|